Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy - Image 1

£146.87

Springer Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Name: Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy
Brand: Springer
Price: 146.45 GBP
Availability: InStock

Decision Making

Price History & Forecast

Last 72 days • 72 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 72 days • 1 price levels

Days at Price

Price Analysis

Most common price: £146 (72 days, 100.0%)

Price range: £146 - £146

Price levels: 1 different prices over 72 days

Description

Very little has been published on optimization of pharmaceutical portfolios. Moreover, most of published literature is coming from the commercial side, where probability of technical success (PoS) is treated as fixed, and not as a consequence of development strategy or design. In this book there is a strong focus on impact of study design on PoS and ultimately on the value of portfolio. Design options that are discussed in different chapters are dose-selection strategies, adaptive design and enrichment. Some development strategies that are discussed are indication sequencing, optimal number of programs and optimal decision criteria. This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As such, it is expected that this book will attract a very broad audience, including decision makers in pharmaceutical R&D, commercial and financial departments. The intended audience also includes portfolio planners and managers, statisticians, decision scientists and clinicians. Early chapters describe approaches to portfolio optimization from big Pharma and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods for optimizing drug development programs and portfolios. Some methodological chapters are technical; however, with a few exceptions they require a relatively basic knowledge of statistics by a reader.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 3319343122
Category: Books > Subjects > Business, Finance & Law > Management > Management Skills > Decision Making
Domain: Amazon UK
Release Date: 23 August 2016
Listed Since: 28 July 2016

Barcode

No barcode data available

Springer Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Global Issues in Pharmaceutical Marketing

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Drug Information: A Guide for Pharmacists, Fourth Edition

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Optimization of Pharmaceutical Processes: 189 (Springer Optimization and Its Applications, 189)

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

The Science and Business of Drug Discovery: Demystifying the Jargon

The Public Financing of Pharmaceuticals: An Economic Approach

Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation

Converging Pharmacy Science and Engineering in Computational Drug Discovery (Advances in Healthcare Information Systems and Administration)

Drug Control and International Law (Routledge Research in International Law)

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Write It Down: Guidance for Preparing Effective and Compliant Documentation

Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

Realoptionen als Controlling-Instrument: Das Beispiel pharmazeutische Forschung und Entwicklung (Unternehmensführung & Controlling)

Pharmaceutical Formulation Design: Recent Practices

Mosby's Textbook for Medication Assistants

Monte Carlo Simulation for the Pharmaceutical Industry: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

Kommunikations-Strategien im Pharma-Markt: Verhaltenswissenschaftliche Ansätze zur Ärzte- und Patienten-Ansprache im Markt für verschreibungspflichtige Präparate: 35 (Konsum und Verhalten, 35)

Viral Polymerases: Structures, Functions and Roles as Antiviral Drug Targets

Mathematical and Statistical Skills in the Biopharmaceutical Industry: A Pragmatic Approach